03 June 2019
Visiongain has published a new pharma report The Ophthalmic Equipment Market Forecast 2019-2029: Vision Care Products, Ophthalmology Surgical Devices, Diagnostic and Monitoring Devices, Consumers, Hospitals, Specialty Clinics and Ambulatory Surgery Centres.
The ophthalmic equipment market is estimated to have reached $51 bn in 2018 and is expected to grow at a CAGR of 7.4% during the forecast period. In 2019, Vision Care Products segment held the biggest market share in the ophthalmic equipment market.
This report profiled the selected companies: Alcon, BAUSCH + LOMB Incorporated, Carl Zeiss Meditec AG, Essilor International S.A., Johnson & Johnson Vision, NIDEK CO., LTD., STAAR Surgical Company, Ziemer Ophthalmic Systems AG and others.
The lead analyst commented that "There is a growing demand for ophthalmic equipment such as vision care products and ophthalmology surgical devices, mainly due to the increasing incidence of myopia across the world. As the myopic population increases globally, it provides opportunity for manufacturers of intraocular lenses to expand their market volume in ophthalmology market. Approval of new technology for correction of myopia would further enhance the opportunity for capitalization.
Rapid rise in the geriatric population across the globe, technological advancements in ophthalmic devices for improving the diagnosis and treatment, increasing adoption of digital devices globally are some of the factors which are expected to drive the growth of ophthalmic equipment market during the forecast period."
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
In clinical trials relating to COVID-19, COVID-19 biobanks will play an important role. These biobanks will play an instrumental role in future scientific studies on the emerging coronavirus (COVID-19) pandemic facing the world.
23 October 2020
Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.
19 October 2020
The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.
12 October 2020
We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.